<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">AJNR Am J Neuroradiol</journal-id><journal-id journal-id-type="iso-abbrev">AJNR Am J Neuroradiol</journal-id><journal-id journal-id-type="pmc-domain-id">3743</journal-id><journal-id journal-id-type="pmc-domain">ajnr</journal-id><journal-title-group><journal-title>AJNR: American Journal of Neuroradiology</journal-title></journal-title-group><issn pub-type="ppub">0195-6108</issn><issn pub-type="epub">1936-959X</issn><publisher><publisher-name>American Society of Neuroradiology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7976526</article-id><article-id pub-id-type="pmcid-ver">PMC7976526.1</article-id><article-id pub-id-type="pmcaid">7976526</article-id><article-id pub-id-type="pmcaiid">7976526</article-id><article-id pub-id-type="pmid">15313712</article-id><article-id pub-id-type="other">03-0741</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Brain</subject></subj-group></article-categories><title-group><article-title>CT and MR Imaging after Placement of the GliaSite Radiation Therapy System to Treat Brain Tumor: Initial Experience</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Matheus</surname><given-names initials="MG">Maria G.</given-names></name><xref ref-type="aff" rid="AFF1">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Castillo</surname><given-names initials="M">Mauricio</given-names></name><xref ref-type="aff" rid="AFF1">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ewend</surname><given-names initials="M">Matthew</given-names></name><xref ref-type="aff" rid="AFF2">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Smith</surname><given-names initials="JK">Jeffrey K.</given-names></name><xref ref-type="aff" rid="AFF1">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Knock</surname><given-names initials="L">Lester</given-names></name><xref ref-type="aff" rid="AFF1">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cush</surname><given-names initials="S">Sharon</given-names></name><xref ref-type="aff" rid="AFF2">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Morris</surname><given-names initials="DE">David E.</given-names></name><xref ref-type="aff" rid="AFF3">c</xref></contrib><aff id="AFF1"><label>a</label>Department of Radiology, University of North Carolina School of Medicine, Chapel Hill</aff><aff id="AFF2"><label>b</label>Department of Neurosurgery, University of North Carolina School of Medicine, Chapel Hill</aff><aff id="AFF3"><label>c</label>Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill</aff></contrib-group><author-notes><corresp>Address reprint requests to Mauricio Castillo, MD, Department of Radiology, University of North Carolina, Chapel Hill, NC 27599</corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2004</year></pub-date><volume>25</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">377939</issue-id><fpage>1211</fpage><lpage>1217</lpage><history><date date-type="accepted"><day>22</day><month>12</month><year>2003</year></date><date date-type="received"><day>30</day><month>9</month><year>2003</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>08</month><year>2005</year></date></event><event event-type="pmc-live"><date><day>25</day><month>05</month><year>2021</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2021-05-26 00:16:32.660"><day>26</day><month>05</month><year>2021</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; American Society of Neuroradiology</copyright-statement><copyright-year>2004</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="1104.pdf"/><abstract><p><italic toggle="yes">BACKGROUND AND PURPOSE:</italic> The GliaSite system delivers local, high radiation after brain tumor resection. We describe the imaging appearance of the device and the changes it causes.</p><p><italic toggle="yes">METHODS:</italic> Eight patients with brain tumors were treated with this system. After surgery, all underwent MR imaging, and one underwent CT. Five were examined 1 month after radioactive unloading and every 2 months thereafter (total, 6&#8211;9 months). Initial studies were assessed for balloon appearance and complications; subsequent studies, for signal intensity and enhancement. Three patients underwent multivoxel proton MR spectroscopy, and one underwent MR perfusion study. Spectra were reviewed for metabolites suggesting tumor; perfusion studies were reviewed for increased relative cerebral blood volume and flow.</p><p><italic toggle="yes">RESULTS:</italic> CT showed the hyperattenuating balloon with considerable artifact. All MR images showed the device and adjacent brain. Follow-up studies showed enhancement and T2 hyperintensity in five patients. In one, enhancement progressively disappeared with no evidence of tumor recurrence. Another patient had progressive enhancement and low relative cerebral blood volume and flow; biopsy showed necrosis and inflammation. One patient had progressive enhancement and high choline levels (proved anaplastic astrocytoma). In another, T2 signal intensity and contrast enhancement progressed owing to tumor and bacterial infection. The last patient had a high choline level (proved radionecrosis); enhancement progressed over 5 months. In three, the device was removed early because of bleeding, mass effect, and therapeutic changes (no follow-up).</p><p><italic toggle="yes">CONCLUSION:</italic> Good balloon visualization was possible with MR imaging. After brachytherapy, all patients developed T2 hyperintensity; stable or progressive enhancement occurred with tumor recurrence and radionecrosis. High choline levels were suggestive of, but not necessarily diagnostic of, tumor.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>hwp-legacy-fpage</meta-name><meta-value>1211</meta-value></custom-meta><custom-meta><meta-name>hwp-legacy-dochead</meta-name><meta-value>Article</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>